Feed Preview

Malaria Vaccines

Malaria Vaccines diagram by undefined

Research for development of a malaria vaccine is currently underway to find an effective modality to control and eliminate the transmission of malaria. To date, no vaccine has been found to be efficacious in fighting against malaria. Here is the latest research on malaria vaccines.

Top 20 most recent papers
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America

Increase of dose associated with decrease in protection against controlled human malaria infection by PfSPZ Vaccine in Tanzanian adults

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of AmericaNovember 29, 2019
Said A JongoStephen L. Hoffman
3
Scientific Reports

Natural Product Inspired Novel Indole based Chiral Scaffold Kills Human Malaria Parasites via Ionic Imbalance Mediated Cell Death

Scientific ReportsNovember 28, 2019
Poonam DangiShailja Singh
Science Translational Medicine

In vitro selection predicts malaria parasite resistance to dihydroorotate dehydrogenase inhibitors in a mouse infection model

Science Translational MedicineDecember 4, 2019
Rebecca E K MandtDyann F. Wirth
Scientific Reports

Amplicon deep sequencing improves Plasmodium falciparum genotyping in clinical trials of antimalarial drugs

Scientific ReportsNovember 28, 2019
Maria GruenbergIngrid Felger
7
bioRxiv

Reticulocyte Infection Leads to Altered Behaviour, Drug Sensitivity and Host Cell Remodelling by Plasmodium falciparum.

bioRxivDecember 2, 2019
Rajesh ChandramohanadasZbynek Bozdech
6
Malaria Journal

High-throughput malaria serosurveillance using a one-step multiplex bead assay

Malaria JournalDecember 4, 2019
Eric W RogierVenkatachalam Udhayakumar
Malaria Journal

En-route to the 'elimination' of genotypic chloroquine resistance in Western and Southern Zambia, 14 years after chloroquine withdrawal

Malaria JournalDecember 3, 2019
Lungowe SitaliBernt Lindtjørn
Malaria Journal

Validation of Plasmodium falciparum dUTPase as the target of 5'-tritylated deoxyuridine analogues with anti-malarial activity

Malaria JournalDecember 3, 2019
Guiomar Pérez-MorenoDolores Gonzalez-Pacanowska
Wellcome Open Research

Controlled Human Malaria Infection in Semi-Immune Kenyan Adults (CHMI-SIKA): a study protocol to investigate in vivo Plasmodium falciparum malaria parasite growth in the context of pre-existing immunity

Wellcome Open ResearchDecember 6, 2018
Melissa Chola KapuluCHMI-SIKA Study Team
The Journal of Immunology : Official Journal of the American Association of Immunologists

Activation of TCR Vδ1+ and Vδ1- Vδ2- γδ T Cells upon Controlled Infection with Plasmodium falciparum in Tanzanian Volunteers

The Journal of Immunology : Official Journal of the American Association of ImmunologistsDecember 4, 2019
Tobias RutishauserGennaro De Libero
BMC Infectious Diseases

Piperaquine concentration and malaria treatment outcomes in Ugandan children treated for severe malaria with intravenous Artesunate or quinine plus Dihydroartemisinin-Piperaquine

BMC Infectious DiseasesDecember 3, 2019
Pauline Byakika-KibwikaJoel Tarning
Children

Infectious Diseases among Refugee Children

ChildrenNovember 27, 2019
Avinash K Shetty
1
Malaria Journal

Forest work and its implications for malaria elimination: a qualitative study

Malaria JournalNovember 27, 2019
Nou SanannChristopher L Pell
20
Malaria Journal

Protection induced by malaria virus-like particles containing codon-optimized AMA-1 of Plasmodium berghei

Malaria JournalDecember 3, 2019
Dong-Hun LeeFu-Shi Quan
Yeast

The wide-ranging phenotypes of ergosterol biosynthesis mutants, and implications for microbial cell factories

YeastDecember 4, 2019
Emily J JohnstonSusan J Rosser
Future Medicinal Chemistry

Design, synthesis, heme binding and density functional theory studies of isoindoline-dione-4-aminoquinolines as potential antiplasmodials

Future Medicinal ChemistryDecember 5, 2019
Anu RaniV Pavan Kumar
ACS Applied Materials & Interfaces

Multipathway Antibacterial Mechanism of a Nanoparticle-Supported Artemisinin Promoted by Nitrogen Plasma Treatment

ACS Applied Materials & InterfacesDecember 4, 2019
Haiying CuiMingdong Dong
Malaria Journal

Utilization patterns of malaria chemoprophylaxis among Tanzanian children attending sickle cell clinic in Dar es Salaam tertiary hospitals

Malaria JournalDecember 3, 2019
Esther J NdegeulayaKennedy Daniel Mwambete
Cell Reports

Decreased K13 Abundance Reduces Hemoglobin Catabolism and Proteotoxic Stress, Underpinning Artemisinin Resistance

Cell ReportsNovember 26, 2019
Tuo YangSimon A Cobbold
42
Malaria Journal

Gametocyte clearance in children, from western Kenya, with uncomplicated Plasmodium falciparum malaria after artemether-lumefantrine or dihydroartemisinin-piperaquine treatment

Malaria JournalDecember 4, 2019
Protus OmondiFrancis Thuo Kimani

See more papers from this feed

Related Feeds

AIDS Malignancies

HIV infection increases the risk of non-communicable diseases common in the aged, including cardiovascular disease, neurocognitive decline, non-aids malignancies, osteoporosis, and frailty. Discover the latest research in AIDS malignancies.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Acute viral rhinopharyngitis

Acute viral rhinopharyngitis, also known as "common cold", is an acute, self-limiting viral infection of the upper respiratory tract involving the nose, sinuses, pharynx and larynx. Discover the latest research on acute viral rhinopharyngitis here.

African Trypanosomiasis

African trypanosomiasis, also known as sleeping sickness, is an insect-borne parasitic disease of humans and other animals. It is caused by protozoa of the species Trypanosoma brucei and almost invariably progresses to death unless treated. Discover the latest research on African trypanosomiasis here.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Amoebiasis

Amoebiasis, infection by the protozoan parasite Entamoeba histolytica, remains a global health problem, despite the availability of effective treatment. Here is the latest research.

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

© 2019 Meta ULC. All rights reserved
/feed-previews/malaria-vaccines/44aa4521-a27f-417a-8746-5185b6dc399b